In addition, these factors also stimulate inflammation-related damage to the nervous system, contributing to ...

Out-of-pocket costs continue to increase for patients who must buy commonly prescribed drugs to treat these five neurological ...

Generic medications reduce the out-of-pocket (OOP) costs for common neurological conditions, apart from multiple sclerosis, ...

A team of international researchers including those from the University of Adelaide have taken a well-known chemical reaction ...

Out-of-pocket costs for drugs for neurologic diseases such as MS, Parkinson's and Alzheimer's disease are climbing sharply, ...

A person battling multiple sclerosis spent an average of $750 in out-of-pocket fees on medicines in 2012, but by 202 ...

Neuropathy, or nerve dysfunction ... If you’re already taking medications, it’s a good idea to talk with your healthcare professional, doctor, or pharmacist before you begin taking CBD ...

A team of international researchers, including scientists from the University of Adelaide, has developed a new approach to pain relief using a well-known chemical reaction. This new method, which ...

[16] The reported incidence in the earlier literature varies from no neuropathy to over 90%. [1],4-8,20] This might be due to differences in patient selection or variation in the criteria used for ...

People with multiple sclerosis spent an average of $750 in out-of-pocket fees on medicines in 2012, and that amount soared to $2,378 annually in 2021, according to a new study. The study  examined the ...

On November 1, Novavax, Inc. (NASDAQ:NVAX) and the U.K. Health Security Agency, representing the U.K. Secretary of State for ...

Vitamins and mineral supplements can help address nutritional deficiencies that commonly affect people who have Crohn’s ...